RISalud
Institutional Health Repository of Andalucía
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/10353| Title: | Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial. |
| Authors: | Mancia, G Cha, G Gil-Extremera, B Harvey, P Lewin, A J Villa, G Kjeldsen, S E |
| metadata.dc.subject.mesh: | Antihypertensive Agents Benzimidazoles Biphenyl Compounds Blood Pressure Calcium Channel Blockers Drug Therapy, Combination Female Humans Hypertension Male Middle Aged Nifedipine Tetrazoles |
| Issue Date: | 11-Aug-2016 |
| Abstract: | The DISTINCT study (reDefining Intervention with Studies Testing Innovative Nifedipine GITS-Candesartan Therapy) investigated the efficacy and safety of nifedipine GITS/candesartan cilexetil combinations vs respective monotherapies and placebo in patients with hypertension. This descriptive sub-analysis examined blood pressure (BP)-lowering effects in high-risk participants, including those with renal impairment (estimated glomerular filtration rate |
| URI: | http://hdl.handle.net/10668/10353 |
| metadata.dc.identifier.doi: | 10.1038/jhh.2016.54 |
| Appears in Collections: | Producción 2020 |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| PMC5301082.pdf | 943,55 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License
